. . . . . . . . . "ampicillin for injection usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions respiratory tract infections treptococcus pneumoniae staphylococcus aureus h influenzae bacterial meningitis septicemia and endocarditis streptococcus spp e coli proteus mirabilis and salmonella spp urinary tract infections e coli roteus mirabilis gastrointestinal infections salmonella typhi salmonella spp shigella spp bacteriology studies to determine the causative organisms and their susceptibility to ampicillin should be performed therapy may be instituted prior to obtaining results of susceptibility testing it is advisable to reserve the parenteral form of this drug for moderately severe and severe infections and for patients who are unable to take the oral forms a change to oral ampicillin may be made as soon as appropriate to reduce the development of drug resistant bacteria and maintain the effectiveness of ampicillin for injection usp and other antibacterial drugs ampicillin for injection usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy indicated surgical procedures should be performed" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "RPb/4u447I0gOpaahehnryCmLEo7h8NGgau12hwMzZ10FsjzfRqyHzVO4wo16B8Ot45pELVp3//skYeJDtcJwqu6eLj0T8E5WrYIYlnSq03SS15AzkEkZPG0gRRn3wm7xj7YfblHnbJyR8ggysHYIfBEKcTeqYtpLuA8Wh8KzTY=" . . "2021-06-27T21:20:31.965+02:00"^^ . . . . .